tTG IgA Test: Normal Range, Results Interpretation & What Your Levels Mean

KEY TAKEAWAYS

What is tTG IgA? The tissue transglutaminase IgA (tTG IgA) test measures antibodies against tissue transglutaminase, an enzyme in the intestinal lining. This test is the most sensitive and specific blood test for screening celiac disease, an autoimmune condition triggered by gluten consumption.

Key points about tTG IgA levels:

• Normal (Negative): <4.0 U/mL - Low likelihood of celiac disease, though doesn't completely rule it out, especially if you have IgA deficiency
• Weak Positive: 4.0-10.0 U/mL - Borderline result that requires additional testing, may indicate early celiac disease or other conditions
• Positive: >10.0 U/mL - High likelihood of celiac disease, confirmation with small intestine biopsy needed before starting treatment
• The test must be done while eating gluten - Going gluten-free before testing can cause false negative results
• Total IgA should be checked simultaneously - About 2-3% of people with celiac disease have IgA deficiency, which makes the tTG IgA test unreliable
• Most accurate celiac screening test - Combined with clinical symptoms and total IgA level, tTG IgA has 90-95% sensitivity and 95-98% specificity for celiac disease

If your tTG IgA is positive, you'll need a small bowel biopsy to confirm celiac disease before starting a gluten-free diet. If negative but symptoms persist, discuss IgA deficiency testing and alternative celiac tests with your doctor.

WHAT IS THE tTG IgA TEST?

The tissue transglutaminase IgA (tTG IgA) test is a blood test that detects IgA antibodies directed against tissue transglutaminase, an enzyme found in the small intestine. When someone with celiac disease eats gluten (a protein found in wheat, barley, and rye), their immune system mistakenly produces these antibodies, which attack both the gluten and the body's own tissue transglutaminase enzyme. This autoimmune reaction damages the small intestine's lining, leading to the malabsorption problems characteristic of celiac disease.

Why is tTG IgA tested?

The tTG IgA test is the primary screening tool for celiac disease. Your doctor may order this test if you have symptoms suggesting celiac disease, such as chronic diarrhea, abdominal pain, bloating, unexplained weight loss, or persistent fatigue. It's also commonly ordered for people with a family history of celiac disease, those with other autoimmune conditions (especially type 1 diabetes or autoimmune thyroid disease), individuals with unexplained iron deficiency anemia, or children with failure to thrive or delayed growth.

How does the test work?

When someone with celiac disease consumes gluten, their immune system produces IgA antibodies against tissue transglutaminase as part of the autoimmune response. The test measures the amount of these antibodies in your blood. Higher levels of tTG IgA antibodies indicate a stronger immune reaction and higher likelihood of active celiac disease. The test requires that you continue eating gluten-containing foods leading up to the blood draw—going gluten-free before testing can cause antibody levels to drop, resulting in a false negative result.

When should you get tested?

You should get tested if you experience persistent digestive symptoms like diarrhea, constipation, bloating, or abdominal pain; have unexplained anemia or fatigue; experience unexplained weight loss; have a first-degree relative with celiac disease; have been diagnosed with another autoimmune condition; have osteoporosis at an early age; experience recurring mouth sores or dental enamel problems; or have an itchy, blistering skin rash (dermatitis herpetiformis). Testing is also important if you're planning to go on a gluten-free diet, as you need to establish a baseline while still eating gluten.

tTG IgA vs. tTG IgG:

The tTG IgA test is more sensitive and specific than the tTG IgG test and is therefore the preferred screening test. However, about 2-3% of people with celiac disease also have selective IgA deficiency, a condition where the body doesn't produce enough IgA antibodies. In these individuals, the tTG IgA test will be falsely negative because they can't produce IgA antibodies at all. This is why total IgA is usually checked at the same time as tTG IgA. If you have IgA deficiency, your doctor will order tTG IgG or deamidated gliadin peptide (DGP) tests instead, which measure different types of antibodies that aren't affected by IgA deficiency.

Connection to gluten and intestinal damage:

Tissue transglutaminase plays a key role in how celiac disease develops. When gluten proteins enter the small intestine, tissue transglutaminase modifies them in a way that makes them more recognizable to the immune system in genetically susceptible people. The immune system then produces antibodies against both the modified gluten and the tissue transglutaminase enzyme itself. These antibodies trigger inflammation that damages the finger-like projections (villi) lining the small intestine, flattening them and reducing the intestine's ability to absorb nutrients. This intestinal damage is the hallmark of celiac disease and the reason for many of its symptoms.

NEGATIVE tTG IgA (<4.0 U/mL)

A negative tTG IgA result (less than 4.0 U/mL) means you have low levels of tissue transglutaminase IgA antibodies in your blood, indicating a low likelihood of celiac disease. However, a negative result doesn't completely rule out celiac disease in all cases.

What does a negative result mean?

If your tTG IgA is negative and your total IgA is normal, celiac disease is unlikely. Most people with an active celiac disease process will have elevated tTG IgA antibodies. A negative result, combined with normal total IgA and no concerning symptoms, generally means you don't need further celiac testing at this time. However, celiac disease can develop at any age, so if symptoms appear later or you're at high risk (such as having a first-degree relative with celiac disease), retesting may be appropriate.

When a negative result might still indicate celiac disease:

False negative results can occur in several situations. If you have selective IgA deficiency (which affects about 2-3% of people with celiac disease versus 0.2% of the general population), your body can't produce IgA antibodies, so the tTG IgA test will always be negative even if you have celiac disease. This is why checking total IgA levels at the same time is crucial. Early in celiac disease, antibody levels may not yet be elevated enough to be detected, especially in young children. Some people with celiac disease have patchy intestinal involvement, meaning not all areas of the intestine are affected, which can lead to lower antibody levels. Additionally, if you've already started reducing gluten in your diet before testing, antibody levels may have dropped enough to produce a negative result.

What if you have symptoms despite a negative result?

If you continue experiencing symptoms suggestive of celiac disease despite a negative tTG IgA test, discuss the following with your doctor: checking your total IgA level to rule out IgA deficiency; considering genetic testing for HLA-DQ2 and HLA-DQ8 (genes strongly associated with celiac disease); testing for other celiac antibodies like deamidated gliadin peptide (DGP) or endomysial antibody (EMA); evaluating for other conditions that can cause similar symptoms, such as inflammatory bowel disease, small intestinal bacterial overgrowth (SIBO), or non-celiac gluten sensitivity; or considering a trial elimination of gluten under medical supervision to see if symptoms improve.

When should you retest?

You should consider retesting if new symptoms develop that weren't present during the initial test; you develop conditions associated with increased celiac risk, such as type 1 diabetes, autoimmune thyroid disease, or Down syndrome; you have a first-degree relative diagnosed with celiac disease after your test; or if you were tested during childhood and now have new symptoms as an adult. Annual testing may be recommended for high-risk individuals with multiple risk factors.

IgA deficiency considerations:

If your total IgA is low or absent, the tTG IgA test is unreliable regardless of the result. Your doctor should order alternative tests like tTG IgG, deamidated gliadin peptide (DGP) IgG, or both. People with IgA deficiency have a 10-20 times higher risk of having celiac disease compared to the general population, so alternative testing is essential if you have symptoms.

Next steps with a negative result:

If you have a negative tTG IgA and normal total IgA with no significant symptoms, no further action is usually needed. Continue eating a normal diet that includes gluten and monitor for any new symptoms. If you develop digestive symptoms, unexplained anemia, fatigue, or other concerning signs in the future, contact your doctor about repeat testing. If symptoms persist despite negative testing, work with your doctor to explore other possible causes of your symptoms. Don't start a gluten-free diet without medical advice, as this can make future testing unreliable if celiac disease is suspected later.

WEAK POSITIVE tTG IgA (4.0-10.0 U/mL)

A weak positive or borderline tTG IgA result (between 4.0 and 10.0 U/mL) means your antibody levels are elevated above the normal range but not high enough to be considered strongly positive. This equivocal result requires careful interpretation and usually additional testing to determine whether you have celiac disease.

What does a weak positive result mean?

A weak positive result is considered equivocal, meaning it's uncertain whether celiac disease is present. Some people with weak positive results do have celiac disease, especially early in the disease process when antibody levels are still rising. However, weak positive results can also occur in people who don't have celiac disease, particularly in those with other autoimmune conditions, chronic liver disease, or certain infections. The result needs to be interpreted in the context of your symptoms, family history, total IgA level, and other clinical factors.

Possible causes of weak positive results:

Early celiac disease is one possible cause—in the initial stages, antibody production is just beginning to increase, so levels may be in the weak positive range before becoming strongly positive. Other autoimmune conditions like type 1 diabetes, Hashimoto's thyroiditis, or rheumatoid arthritis can sometimes cause mildly elevated tTG IgA without celiac disease being present. Chronic liver disease (such as autoimmune hepatitis or cirrhosis) can lead to weak positive results. Certain infections, particularly in the gastrointestinal tract, may temporarily elevate antibody levels. Heart failure has been associated with mildly elevated tTG IgA in some studies. Finally, some people may have weak positive results with no identifiable cause, which may normalize over time without treatment.

What additional testing is needed?

Your doctor will likely recommend several follow-up tests. A repeat tTG IgA test in 3-6 months can determine if antibody levels are rising (suggesting active celiac disease), stable, or falling. Testing for other celiac antibodies like endomysial antibody (EMA) IgA, which is highly specific for celiac disease, or deamidated gliadin peptide (DGP) antibodies can provide additional evidence. Genetic testing for HLA-DQ2 and HLA-DQ8 is valuable because about 95-99% of people with celiac disease carry one or both of these genes. If you don't have these genes, celiac disease is extremely unlikely. Confirming that your total IgA level is normal ensures the tTG IgA test is reliable.

When is biopsy recommended?

A small intestine biopsy may be recommended if you have a weak positive result along with symptoms strongly suggesting celiac disease (such as chronic diarrhea, unexplained weight loss, or severe nutritional deficiencies); a family history of celiac disease; other positive celiac antibodies; positive genetic testing for HLA-DQ2 or HLA-DQ8; or if antibody levels are rising on repeat testing. The biopsy remains the gold standard for diagnosing celiac disease and can definitively show whether the characteristic intestinal damage is present.

Monitoring approach if biopsy isn't done immediately:

If your doctor decides not to proceed with a biopsy right away, you'll typically be monitored with repeat tTG IgA testing every 3-6 months to track antibody trends. You should continue eating a normal gluten-containing diet during this monitoring period, as going gluten-free will make interpretation of future tests difficult. Keep track of any symptoms—if they worsen or new symptoms develop, contact your doctor, as this may prompt moving forward with a biopsy. If you have symptoms that improve with a gluten-free diet, this should be discussed with your doctor before making permanent dietary changes.

Clinical context importance:

The interpretation of a weak positive result depends heavily on your individual situation. Someone with chronic digestive symptoms, unexplained anemia, and a mother with celiac disease is much more likely to have celiac disease with a weak positive result than someone with no symptoms and no risk factors. Your age, gender, ethnicity, other health conditions, and medication use can all influence how the result should be interpreted. This is why weak positive results require an individualized approach rather than automatic treatment.

What not to do:

Don't start a gluten-free diet based solely on a weak positive result before completing additional testing and consulting with your doctor. Starting a gluten-free diet will cause antibody levels to drop and intestinal healing to begin, which can lead to false negative results on future tests and make diagnosis impossible without reintroducing gluten. Don't ignore the result—while not definitive, a weak positive result deserves follow-up to ensure celiac disease isn't missed in its early stages.

POSITIVE tTG IgA (>10.0 U/mL)

A positive tTG IgA result (greater than 10.0 U/mL) indicates significantly elevated levels of tissue transglutaminase IgA antibodies, suggesting a high likelihood of celiac disease. However, even with a positive result, confirmation through small intestine biopsy is required before making a definitive diagnosis and starting treatment.

What does a positive result mean?

A positive tTG IgA result means your immune system is producing substantial amounts of antibodies against tissue transglutaminase, the enzyme in your intestinal lining. This autoimmune response is highly specific for celiac disease. The higher your tTG IgA level, the more likely you have celiac disease—levels greater than 100 U/mL (more than 10 times the upper limit of normal) are particularly specific and strongly indicate active celiac disease. However, positive results can occasionally occur in other conditions, which is why biopsy confirmation is standard practice before committing to lifelong dietary changes.

Why is biopsy confirmation needed?

The small intestine biopsy is considered the gold standard for diagnosing celiac disease. During an upper endoscopy procedure, your gastroenterologist will take several small tissue samples from your small intestine to examine under a microscope. Celiac disease causes characteristic changes to the intestinal lining, including villous atrophy (flattening of the finger-like projections that absorb nutrients), crypt hyperplasia (deepening of the intestinal glands), and increased inflammatory cells. The biopsy confirms that these tissue changes are present and rules out other conditions that might cause positive antibody tests.

What does the biopsy show?

In celiac disease, the biopsy typically shows varying degrees of intestinal damage, graded on the Marsh scale. Marsh 1 shows increased lymphocytes (immune cells) in the intestinal lining but no architectural changes. Marsh 2 shows the development of crypt hyperplasia (elongation of intestinal crypts). Marsh 3 shows villous atrophy ranging from partial to complete flattening, which is the classic finding in celiac disease and causes malabsorption. The degree of damage doesn't always correlate with symptom severity—some people with extensive damage have minimal symptoms, while others with milder damage feel very unwell.

Strongly positive levels (>100 U/mL):

When tTG IgA levels are very high (typically greater than 10 times the upper limit of normal, or above 100 U/mL in most labs), the specificity for celiac disease approaches 100%. Some European guidelines allow for diagnosis without biopsy in symptomatic children with tTG IgA levels greater than 10 times the upper limit of normal, a positive EMA antibody, and genetic confirmation. However, in the United States and for adults, biopsy is still recommended regardless of how high the antibody levels are, as it provides definitive confirmation and a baseline assessment of intestinal damage.

What happens next?

After a positive tTG IgA result, your doctor will refer you to a gastroenterologist for an upper endoscopy and biopsy. It's crucial to continue eating gluten-containing foods (at least 1-2 servings daily) until after the biopsy is completed, as going gluten-free can allow the intestine to begin healing, potentially leading to a false negative biopsy even though you have celiac disease. The endoscopy is typically done as an outpatient procedure under sedation. Your gastroenterologist will also check for other celiac antibodies and assess for nutritional deficiencies common in celiac disease, such as iron, vitamin D, vitamin B12, and folate.

Critical: Do NOT start a gluten-free diet before biopsy:

This is one of the most important pieces of advice. Even though you may be eager to feel better, starting a gluten-free diet before your biopsy can cause the intestinal damage to heal partially or completely, making it impossible to confirm the diagnosis. If the biopsy is negative because you've already started avoiding gluten, you'll face a difficult choice: either assume you have celiac disease and stay on a strict gluten-free diet forever without definitive diagnosis, or undergo a "gluten challenge" (eating gluten again for several months) to allow damage to redevelop so you can be properly diagnosed. Both options are suboptimal compared to simply continuing gluten until diagnosis is confirmed.

Treatment: Lifelong gluten-free diet:

Once celiac disease is confirmed by biopsy, the treatment is a strict, lifelong gluten-free diet. This means completely avoiding wheat, barley, rye, and any products containing these grains. Even small amounts of gluten (as little as 10-50 mg, about 1/8 of a slice of bread) can trigger intestinal damage in people with celiac disease. The gluten-free diet must be very strict—you need to learn to read labels carefully, avoid cross-contamination, and be cautious when eating out. Many packaged foods, medications, supplements, and even some personal care products can contain hidden gluten. Working with a registered dietitian experienced in celiac disease is highly recommended to ensure your diet is both gluten-free and nutritionally complete.

Monitoring response with tTG IgA:

After starting a gluten-free diet, your tTG IgA levels should gradually decrease and typically normalize within 6-12 months if you're strictly avoiding gluten. Your doctor will recheck your tTG IgA at 3-6 months after diagnosis and then annually to ensure levels are declining and eventually reach normal range. Persistently elevated levels despite dietary adherence may indicate hidden gluten exposure, poor dietary compliance, or rarely, refractory celiac disease (a condition where intestinal damage persists despite strict gluten avoidance). Some people's antibody levels take longer to normalize, especially if they were very high at diagnosis.

Complications if untreated:

Untreated celiac disease can lead to numerous serious complications. Chronic malabsorption causes nutritional deficiencies including iron deficiency anemia, osteoporosis (from calcium and vitamin D deficiency), vitamin B12 and folate deficiency. Growth problems and delayed puberty can occur in children. Untreated celiac disease is associated with increased risk of developing other autoimmune conditions like type 1 diabetes, autoimmune thyroid disease, and Sjögren's syndrome. Fertility problems and pregnancy complications including recurrent miscarriage and low birth weight babies are more common. Most seriously, long-standing untreated celiac disease slightly increases the risk of certain cancers, particularly small bowel lymphoma, though this remains rare even in untreated patients. Following a strict gluten-free diet substantially reduces or eliminates most of these risks.

Prognosis with treatment:

The prognosis for people with celiac disease who follow a strict gluten-free diet is excellent. Most people notice symptom improvement within days to weeks of starting the diet, though complete intestinal healing takes longer—typically 6-24 months in adults. Once the intestine heals and antibodies normalize, the risk of complications returns to that of the general population. Many people with celiac disease can live completely normal, healthy lives on a gluten-free diet. The main challenges are the strictness required (even trace amounts of gluten can cause damage), the higher cost of gluten-free foods, and social situations involving food. Support groups, either online or in-person, can be extremely helpful for learning to navigate these challenges.

SPECIFIC VALUE INTERPRETATIONS

Understanding what your specific tTG IgA value means can help you interpret your results and know what to expect next. Here are interpretations for commonly searched values:

tTG IgA <0.5 U/mL or 0.2 U/mL: These very low values are well below the negative cutoff (<4.0 U/mL) and indicate virtually no tissue transglutaminase IgA antibodies in your blood. Celiac disease is very unlikely with values this low, assuming your total IgA is normal. These results are considered normal and don't require any follow-up unless you develop symptoms in the future.

tTG IgA 0.5 U/mL: This is a negative result, well below the 4.0 U/mL cutoff. You have minimal tTG IgA antibodies, which is normal. If your total IgA is normal and you have no symptoms, celiac disease is very unlikely and no further testing is needed at this time.

tTG IgA 1.0 U/mL: This value is negative and in the normal range. You have very low levels of tTG IgA antibodies, which doesn't suggest celiac disease. Continue eating normally and monitor for any new symptoms. If you develop digestive symptoms, unexplained anemia, or other concerning signs in the future, discuss repeat testing with your doctor.

tTG IgA 1.2 U/mL: This is a negative result, clearly below the 4.0 U/mL cutoff. Your antibody level is low and doesn't indicate celiac disease, assuming your total IgA level is normal. No action is needed unless symptoms develop later.

tTG IgA 1.9 U/mL: While still negative (below 4.0 U/mL), this value is closer to the cutoff than lower values. For most people, this is simply a normal result with no clinical significance. However, if you have strong symptoms suggesting celiac disease or significant risk factors (like a first-degree relative with celiac disease), your doctor might consider monitoring with repeat testing in 6-12 months to ensure the level isn't gradually rising toward the positive range.

tTG IgA 2.0 U/mL or <2.0 U/mL: This is a very commonly reported value format and represents a negative result. Many labs report results below 2.0 U/mL simply as "<2.0" because the exact value isn't clinically significant when it's this low. This result indicates you don't have elevated tTG IgA antibodies and celiac disease is unlikely. No further action is needed unless symptoms develop.

tTG IgA 4.0-6.0 U/mL: These values fall in the weak positive or borderline range. This is considered equivocal—celiac disease is possible but not certain. Your doctor will likely recommend additional testing, including repeat tTG IgA in 3-6 months, testing for other celiac antibodies (like EMA), and possibly genetic testing. If you have symptoms or risk factors, a small intestine biopsy may be recommended to definitively determine if celiac disease is present. Don't start a gluten-free diet yet, as continued gluten consumption is necessary for accurate follow-up testing.

tTG IgA 6.0-10.0 U/mL: Values in this range are weak positive and require follow-up. Celiac disease is possible, especially if you have symptoms, positive family history, or other risk factors. Your doctor will typically order additional celiac antibodies and may refer you to a gastroenterologist for biopsy consideration. Some people in this range have early celiac disease with antibody levels that will continue rising if gluten consumption continues, while others may have mildly elevated levels that remain stable and don't represent celiac disease. Repeat testing helps clarify which category you fall into.

tTG IgA >10.0 U/mL: This is a positive result indicating high likelihood of celiac disease. You should be referred to a gastroenterologist for small intestine biopsy to confirm the diagnosis. Continue eating gluten until after the biopsy is completed. Don't start a gluten-free diet yet, even if you feel unwell, as this can interfere with diagnostic testing.

tTG IgA 20-50 U/mL: These moderately elevated values strongly suggest celiac disease. Biopsy is needed for confirmation. The intestinal damage is likely present and moderate in extent. Once celiac disease is confirmed, a strict gluten-free diet will be necessary.

tTG IgA 50-100 U/mL: These high values are very specific for celiac disease. Biopsy confirmation is still standard, but celiac disease is very likely. Significant intestinal damage is probably present. After confirmation, strict gluten-free diet is essential.

tTG IgA >100 U/mL: Values greater than 100 U/mL (more than 10 times the upper limit of normal in most labs) are considered strongly positive. Celiac disease is almost certain, and extensive intestinal damage is likely present. While biopsy confirmation is still recommended in adults in the United States, some international guidelines allow for diagnosis without biopsy in children with levels this high (along with positive EMA antibody and genetic confirmation). Your antibody levels may take 12-18 months or longer to normalize after starting a gluten-free diet due to the very high starting point.

QUICK INTERPRETATION TABLE

Timeline for follow-up:

• Negative result: No urgent follow-up needed; annual testing if high-risk
• Weak positive: Repeat testing in 3-6 months; see doctor within 2-4 weeks to discuss
• Positive (10-50): Gastroenterology appointment within 2-4 weeks; biopsy within 1-2 months
• Strongly positive (>100): Gastroenterology appointment within 1-2 weeks; biopsy as soon as possible

WHEN TO WORRY: URGENCY FRAMEWORK

Understanding when your tTG IgA result requires immediate attention versus routine follow-up can help you take appropriate action without unnecessary anxiety.

IMMEDIATE MEDICAL ATTENTION (Emergency Room or Same Day):

Seek immediate medical care if you have a positive or weak positive tTG IgA result combined with:

• Severe abdominal pain that is constant or getting worse, especially if accompanied by fever
• Signs of bowel obstruction or perforation: Severe bloating, inability to pass gas or stool, vomiting, severe constipation
• Severe malnutrition or wasting: Dramatic unintentional weight loss (more than 10-15% of body weight), severe muscle wasting, signs of severe dehydration
• Neurological symptoms: Severe imbalance or difficulty walking, confusion, seizures, severe unrelenting headaches
• Severe bleeding: Black or bloody stools, vomiting blood, signs of severe anemia (extreme pallor, fainting, rapid heartbeat at rest)

While these severe complications are rare with newly diagnosed celiac disease, they can occur with long-standing untreated disease and require immediate evaluation.

URGENT (See Doctor Within 1-2 Weeks):

Schedule an urgent appointment if you have:

• First-time positive result (>10.0 U/mL): This indicates high likelihood of celiac disease and requires prompt gastroenterology referral and biopsy planning
• Weak positive result with significant symptoms: Chronic diarrhea lasting more than 2 weeks, unexplained weight loss (more than 5-10 pounds without trying), persistent vomiting, signs of malnutrition
• Severe anemia: Hemoglobin below 10 g/dL, symptoms like extreme fatigue, shortness of breath with minimal exertion, chest pain
• Osteoporosis or fractures at young age: Particularly if you're premenopausal or male under 50, as this may indicate long-standing undiagnosed celiac disease
• Unexplained elevated liver enzymes along with positive tTG IgA
• Pregnancy with positive result: Important to diagnose and treat celiac disease during pregnancy to optimize outcomes

ROUTINE (Schedule Within 1-2 Months):

These situations warrant medical attention but aren't emergencies:

• Weak positive result (4.0-10.0 U/mL) without severe symptoms: Needs follow-up testing and monitoring but not urgent
• Positive result with mild or moderate symptoms: Digestive discomfort, mild bloating, fatigue that isn't debilitating
• Need for gastroenterology referral and biopsy scheduling after positive test result
• Follow-up appointment after starting gluten-free diet to check antibody levels and assess symptom improvement
• Rising antibody levels on repeat testing: Suggests active disease process requiring evaluation
• Monitoring in diagnosed celiac disease: Regular check-ups to ensure dietary compliance and assess for complications

NO URGENT CONCERN (Routine Monitoring):

These situations don't require urgent attention:

• Negative result (<4.0 U/mL) with no symptoms: Celiac disease unlikely, routine monitoring appropriate
• Stable negative results in high-risk individuals: Annual or biennial testing may be recommended
• Successfully treated celiac disease with normalized antibodies: Continue strict gluten-free diet, see doctor annually
• Mild, stable symptoms with negative test results: Work with doctor to explore other causes at routine visit

Special considerations:

If you're a child with positive tTG IgA, prompt evaluation is particularly important as untreated celiac disease can affect growth and development. If you have diabetes (especially type 1) and positive tTG IgA, relatively prompt evaluation is warranted as celiac disease can affect blood sugar control. If you're trying to conceive or are pregnant with newly discovered positive tTG IgA, timely diagnosis and treatment can improve pregnancy outcomes.

What not to do while waiting:

Don't start a gluten-free diet before your biopsy is completed, even if you have to wait several weeks for the procedure. Removing gluten from your diet can cause intestinal healing and antibody levels to drop, potentially leading to false negative results and making diagnosis impossible. Don't panic if you have to wait a few weeks for specialist appointments—celiac disease that has been present for months or years won't dramatically worsen in a few additional weeks while you await proper diagnosis.

CELIAC DISEASE: COMPREHENSIVE OVERVIEW

What is Celiac Disease?

Celiac disease is an autoimmune disorder in which the ingestion of gluten triggers an immune response that damages the small intestine. Gluten is a protein found in wheat, barley, and rye. When people with celiac disease eat gluten, their immune system mistakenly attacks the lining of the small intestine, specifically targeting the finger-like projections called villi that line the intestinal wall. These villi are responsible for absorbing nutrients from food. As they become damaged and flattened (a condition called villous atrophy), the body loses its ability to absorb nutrients effectively, leading to malnutrition and a wide range of symptoms affecting multiple organ systems.

Celiac disease affects approximately 1% of the worldwide population, making it one of the most common genetic disorders. However, it's significantly underdiagnosed—studies suggest that for every diagnosed case, there are 5-10 undiagnosed cases. The condition can develop at any age, from early childhood through late adulthood. There's a strong genetic component: if you have a first-degree relative (parent, sibling, or child) with celiac disease, you have a 10% chance of developing it yourself compared to the 1% risk in the general population.

How tTG IgA Helps Diagnose Celiac Disease:

The tTG IgA test is the cornerstone of celiac disease screening because it detects a specific autoimmune response characteristic of the condition. When someone with celiac disease consumes gluten, an enzyme in the small intestine called tissue transglutaminase (tTG) interacts with gluten proteins. In susceptible individuals, the immune system produces IgA antibodies that attack both the gluten and the tissue transglutaminase itself. These anti-tTG IgA antibodies are highly specific for celiac disease, making the test very accurate.

The tTG IgA test is typically the first test ordered when celiac disease is suspected. It's part of a celiac antibody panel that usually includes total IgA (to rule out IgA deficiency, which would make the tTG IgA test unreliable) and may include other antibodies like deamidated gliadin peptide (DGP) or endomysial antibody (EMA). The sensitivity of the tTG IgA test is 90-95%, meaning it correctly identifies 90-95% of people who have celiac disease. Its specificity is 95-98%, meaning that 95-98% of people with positive results actually have the disease.

Importantly, tTG IgA levels correlate with disease activity and intestinal damage severity. Higher antibody levels generally indicate more extensive intestinal damage, though this correlation isn't perfect—some people with severe symptoms have only moderately elevated antibodies, while others with extensive intestinal damage have minimal symptoms. After starting a gluten-free diet, tTG IgA levels gradually decrease and typically normalize within 6-12 months, making the test useful for monitoring dietary compliance and disease control.

Diagnostic Criteria for Celiac Disease:

Celiac disease diagnosis in the United States requires meeting several criteria. The gold standard is a combination of positive serology (elevated celiac antibodies like tTG IgA) and positive small intestine biopsy showing characteristic intestinal damage. The biopsy must show villous atrophy, crypt hyperplasia (elongation of intestinal glands), or increased intraepithelial lymphocytes (immune cells in the intestinal lining). Clinical response to a gluten-free diet supports the diagnosis, as symptoms should improve and antibodies should normalize with strict gluten avoidance.

Some countries in Europe have adopted alternative diagnostic criteria for certain situations. Symptomatic children with very high tTG IgA levels (greater than 10 times the upper limit of normal), positive endomysial antibody, and genetic confirmation of HLA-DQ2 or HLA-DQ8 may be diagnosed without biopsy in some European countries. However, this approach isn't widely accepted in the United States, where biopsy remains standard for diagnosis regardless of antibody levels.

Genetic testing for HLA-DQ2 and HLA-DQ8 plays a supporting role in diagnosis. About 95% of people with celiac disease carry HLA-DQ2, and most of the remaining 5% carry HLA-DQ8. If you don't have either of these genetic markers, celiac disease is extremely unlikely (negative predictive value greater than 99%). However, about 30-40% of the general population carries these genes, so having them doesn't mean you have celiac disease—it just means you have the genetic predisposition. Genetic testing is most useful for ruling out celiac disease or assessing risk in family members of people with celiac disease.

Symptoms of Celiac Disease:

Celiac disease symptoms are highly variable, ranging from severe and obvious to mild or completely absent. Traditional gastrointestinal symptoms include chronic diarrhea (the most common symptom in children), abdominal pain and cramping, bloating and gas, constipation (can occur instead of or alternating with diarrhea), nausea and vomiting, pale, foul-smelling, fatty stools (steatorrhea) that float, and weight loss or failure to gain weight (especially in children).

However, many people with celiac disease have few or no digestive symptoms. Systemic manifestations can be the primary presentation and include iron deficiency anemia that doesn't respond to iron supplementation, chronic fatigue and weakness, osteoporosis or osteopenia at a young age, elevated liver enzymes, peripheral neuropathy (numbness and tingling in hands and feet), balance problems and ataxia, delayed growth and short stature in children, delayed puberty, infertility and recurrent miscarriage, and mouth ulcers.

Dermatitis herpetiformis is a specific skin manifestation of celiac disease. It presents as an intensely itchy, blistering rash typically appearing on elbows, knees, buttocks, and scalp. Nearly everyone with dermatitis herpetiformis has celiac disease, even if they don't have digestive symptoms. The rash responds to a gluten-free diet, though improvement takes longer than gastrointestinal symptoms.

Neurological and psychiatric symptoms associated with celiac disease include headaches and migraines, anxiety and depression, attention and concentration difficulties, brain fog, seizures (rarely), and cognitive impairment. Reproductive issues include delayed menarche, irregular menstrual periods, infertility in both men and women, recurrent miscarriages, low birth weight babies, and premature birth.

Many people have "silent celiac disease," meaning they have positive antibodies and intestinal damage on biopsy but no symptoms, or symptoms so mild they've never sought medical attention. These individuals are often diagnosed through screening of high-risk groups or incidentally when tested for other reasons. Despite the lack of symptoms, silent celiac disease still causes intestinal damage and increases risk of complications, so treatment with a gluten-free diet is still recommended.

Treatment: The Gluten-Free Diet

The only treatment for celiac disease is a strict, lifelong gluten-free diet. This means completely eliminating wheat, barley, rye, and any products containing these grains. Even tiny amounts of gluten—as little as 10-50 milligrams (about 1/8 of a slice of bread)—can trigger intestinal damage in sensitive individuals. "Mostly" gluten-free isn't sufficient; the diet must be strictly and completely gluten-free.

Foods to avoid include anything containing wheat (all varieties including spelt, kamut, farro, durum, semolina), barley (including malt and malt flavoring), rye, triticale (a wheat-rye hybrid), and most oats unless specifically labeled gluten-free (oats are naturally gluten-free but are almost always contaminated with wheat during growing and processing).

Many processed foods contain hidden gluten. You must read labels carefully and look for wheat, barley, rye, malt, brewer's yeast, and derivatives like hydrolyzed wheat protein or wheat starch. In the United States, foods labeled "gluten-free" must contain less than 20 parts per million (ppm) of gluten, which is considered safe for most people with celiac disease. Be cautious with products like soy sauce (usually contains wheat), beer (made from barley), some candies and chocolates, processed meats and hot dogs, soup mixes and bouillon, salad dressings, and even some medications and supplements.

Cross-contamination is a significant concern. Gluten-free foods can become contaminated by contact with gluten-containing foods during preparation. Use separate cutting boards, toasters, colanders, and other cooking utensils for gluten-free foods. Clean surfaces thoroughly before preparing gluten-free meals. Be extremely careful when eating out—even "gluten-free" restaurant foods can be cross-contaminated in kitchens where gluten-containing foods are prepared. Many people with celiac disease carry gluten-free snacks and research restaurants in advance to find those with dedicated gluten-free preparation areas.

Working with a registered dietitian who specializes in celiac disease is highly recommended. The dietitian can help ensure your gluten-free diet is nutritionally complete (some gluten-free products are lower in fiber, B vitamins, and iron than their gluten-containing counterparts); teach you how to read labels effectively; help you navigate social situations and dining out; identify hidden sources of gluten; and address any nutritional deficiencies through diet or supplementation.

Nutritional supplementation is often necessary, at least initially. Common supplements include iron (for anemia), calcium and vitamin D (for bone health), vitamin B12, folate, zinc, and a general multivitamin. Your doctor will monitor your nutritional status through periodic blood tests and adjust supplementation as needed. Many deficiencies resolve once the intestine heals and absorption improves, though some people need ongoing supplementation.

Monitoring with tTG IgA After Diagnosis:

After starting a gluten-free diet, your tTG IgA levels should be monitored to ensure they're declining and eventually normalize. Typical monitoring includes testing at 3-6 months after diagnosis to document that antibody levels are dropping, then at 12 months to see if they've normalized, and annually thereafter to ensure continued dietary compliance and disease control.

Most people's tTG IgA levels decline significantly within 6 months of starting a strict gluten-free diet and normalize (fall below 4.0 U/mL) within 12-18 months. People who had very high antibody levels at diagnosis (above 100 U/mL) may take longer—up to 2-5 years in some cases—for antibodies to fully normalize, even with perfect dietary compliance. Children's antibodies typically normalize faster than adults'.

Persistently elevated tTG IgA despite reported strict gluten-free diet adherence suggests several possibilities: inadvertent gluten exposure from hidden sources, poor dietary compliance (either intentional or lack of understanding of what contains gluten), cross-contamination, medications or supplements containing gluten, or rarely, refractory celiac disease (a complication where intestinal damage persists despite strict gluten avoidance).

If your antibodies aren't declining as expected, your doctor will review your diet in detail, potentially referring you back to a dietitian; check for hidden gluten sources; assess for cross-contamination issues; review your medications and supplements for gluten content; and consider repeat endoscopy to assess whether intestinal healing is occurring despite elevated antibodies. In very rare cases of truly refractory celiac disease (where intestinal damage persists after 12 months of documented strict gluten-free diet), specialized treatment may be needed.

Complications of Untreated Celiac Disease:

Long-standing untreated celiac disease can lead to numerous serious complications. Nutritional deficiencies are common and include iron deficiency anemia (affecting up to 40% of people at diagnosis), vitamin D and calcium deficiency leading to osteoporosis and increased fracture risk, vitamin B12 deficiency causing fatigue and neurological symptoms, folate deficiency, fat-soluble vitamin deficiencies (A, D, E, K), and protein malnutrition.

Bone disease is a major complication. Up to 75% of people with newly diagnosed celiac disease have decreased bone mineral density (osteopenia or osteoporosis), even young adults who would normally have peak bone mass. This occurs because calcium and vitamin D malabsorption, chronic inflammation, and hormonal factors all affect bone metabolism. Untreated celiac disease significantly increases fracture risk.

Reproductive problems are more common in untreated celiac disease. Women may experience delayed menarche, irregular or absent menstrual periods, early menopause, infertility, recurrent miscarriages (2-3 times higher risk), intrauterine growth restriction, and low birth weight babies. Men may have reduced fertility due to hormonal changes and nutritional deficiencies. Many of these issues improve or resolve with a gluten-free diet.

Growth problems and developmental delays occur in children with untreated celiac disease. Short stature, delayed puberty, dental enamel defects, and failure to thrive are all associated with untreated childhood celiac disease. Catching and treating celiac disease early in childhood can prevent or minimize these problems.

Increased risk of other autoimmune conditions is well-established. People with celiac disease have higher rates of type 1 diabetes (10% of people with type 1 diabetes have celiac disease), autoimmune thyroid disease (Hashimoto's thyroiditis or Graves' disease), autoimmune hepatitis, primary biliary cholangitis, Sjögren's syndrome, Addison's disease, and rheumatoid arthritis. The risk is highest if celiac disease is untreated for prolonged periods.

Malignancy risk, particularly small bowel lymphoma (enteropathy-associated T-cell lymphoma or EATL), is slightly increased in untreated celiac disease, though the absolute risk remains low. The risk of small bowel adenocarcinoma and non-Hodgkin lymphoma is also slightly elevated. Following a strict gluten-free diet substantially reduces or eliminates this increased cancer risk, especially if the diet is started early in the disease course.

Refractory celiac disease is a rare but serious complication occurring in less than 5% of celiac disease patients. It's defined as persistent or recurrent malabsorption symptoms and villous atrophy despite strict gluten-free diet adherence for at least 12 months. Type 1 refractory celiac disease generally responds to immunosuppressive therapy, while type 2 is more severe and associated with risk of progression to lymphoma.

Prognosis with Treatment:

The prognosis for people with celiac disease who follow a strict gluten-free diet is excellent. Most people notice symptom improvement within days to weeks of starting the diet—digestive symptoms often improve first, while nutritional deficiencies and bone density take longer to correct. Intestinal healing typically occurs over 6-24 months in adults (faster in children), with villi gradually returning to normal or near-normal architecture.

Once the intestine heals and antibodies normalize, people with celiac disease on a strict gluten-free diet have the same life expectancy and quality of life as the general population. The risk of complications, including nutritional deficiencies, osteoporosis, and malignancy, returns to population baseline with long-term dietary adherence. Many people report improved energy, better concentration, resolution of chronic symptoms they'd accepted as normal, and overall improved quality of life.

Nutritional status normalizes with intestinal healing. Anemia resolves in most people within 6-12 months of starting a gluten-free diet. Bone density improves, with the greatest gains occurring in the first year after diagnosis, particularly in children and young adults. Vitamin and mineral levels normalize as absorption improves, though some people need ongoing supplementation.

The main challenges are maintaining strict gluten avoidance (even trace amounts can cause damage), the higher cost of gluten-free foods compared to conventional equivalents, social situations involving food (restaurants, travel, celebrations), hidden sources of gluten in processed foods and medications, and the psychological adjustment to a restricted diet. Support groups, either online or in person through local celiac disease associations, can be invaluable for learning practical strategies and maintaining motivation.

Long-term outcomes depend heavily on dietary adherence. People who are strictly gluten-free have excellent outcomes with minimal complications. Those who are only partially adherent or who frequently consume gluten continue to experience intestinal damage, nutritional problems, and elevated complication risks. Regular follow-up with your doctor, annual monitoring of celiac antibodies and nutritional status, and working with a dietitian for ongoing support are key to long-term success.